Therapeutic options for neuromuscular diseases

Veterinary Clinics of North America - Small Animal Practice

Volumn 34, Issue 6 SPEC.ISS., 2004, Pages 1525-1551

  Kent, Marc ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZATHIOPRINE; CANITOR; CARNITINE; CHOLINESTERASE INHIBITOR; CIMETIDINE; CLINDAMYCIN; CLINDAMYCIN PHOSPHATE; COTRIMAZINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DECOQUINATE; DEXAMETHASONE; GAMMAGARD S D; GAMMAR P; GLUCOCORTICOID; IMMUNOGLOBULIN; IVVEEGAM EN; METHYLPREDNISOLONE SODIUM SUCCINATE; MISOPROSTOL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEOSTIGMINE; OMEPRAZOLE; PREDNISOLONE; PREDNISOLONE SODIUM SUCCINATE; PREDNISONE; PYRIDOSTIGMINE; PYRIMETHAMINE; SUCRALFATE; SULFONAMIDE; TRIMETHOPRIM; UBIDECARENONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL DISEASE; CAT DISEASE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLOSTRIDIUM DIFFICILE; DERMATOMYOSITIS; DIAGNOSTIC TEST; DOG DISEASE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG MECHANISM; DRUG TISSUE LEVEL; GUILLAIN BARRE SYNDROME; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOLOGY; INCLUSION BODY MYOSITIS; INFLAMMATORY DISEASE; MEDICAL DECISION MAKING; MOTOR NEURON DISEASE; MUSCLE BIOPSY; MYASTHENIA GRAVIS; MYOPATHY; MYOSITIS; NEOSPORA CANINUM; NERVE BIOPSY; NEUROMUSCULAR DISEASE; NONHUMAN; POLYMYOSITIS; PROTOZOAL INFECTION; REVIEW; TOXOPLASMA GONDII; TOXOPLASMOSIS; TREATMENT PLANNING; ZOONOSIS;

EID: 5044250153     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvsm.2004.05.013     Document Type: Review

References (136)

1. E.N. Glass M. Kent The clinical examination for neuromuscular disease Vet Clin N Am Small Anim Pract 32 1 2002 1-29
2. P.A. Cuddon Electrophysiology in neuromuscular disease Vet Clin N Am Small Anim Pract 32 1 2002 31-62
3. P.J. Dickinson R.A. LeCouteur Muscle and nerve biopsy Vet Clin N Am Small Anim Pract 32 1 2002 63-102
4. M.G. Papich J.E. Riviere Chloramphenicol and derivatives, macrolides, lincosamides, and miscellaneous antimicrobials In: Adams editor. Veterinary pharmacology and therapeutics 2001 Iowa State University Press Ames, IA 868-897
5. M. Camps G. Arrizabalaga J. Boothroyd An rRNA mutation identifies the apicoplast as the target for clindamycin in Toxoplasma gondii Mol Microbiol 43 5 2002 1309-1318
6. J. Harari J. Lincoln Pharmacologic features of clindamycin in dogs and cats J Am Vet Med Assoc 195 1 1989 124-125
7. J.P. Dubey M.R. Lappin Toxoplasmosis and neosporosis In: C.E. Greene editor. Infectious diseases of the dog and cat 1998 WB Saunders Philadelphia 493-509
8. M.R. Lappin C.E. Greene S. Winston S.L. Toll M.E. Epstein Clinical feline toxoplasmosis - serologic diagnosis and therapeutic management of 15 cases J Vet Intern Med 3 3 1989 139-143
9. M.G. Davidson M.R. Lappin J.R. Rottman M.B. Tompkins R.V. English A.T. Bruce et al. Paradoxical effect of clindamycin in experimental, acute toxoplasmosis in cats Antimicrob Agents Chemother 40 6 1996 1352-1359
10. C.E. Greene J.R. Cook Jr. E.A. Mahaffey Clindamycin for treatment of Toxoplasma polymyositis in a dog J Am Vet Med Assoc 187 6 1985 631-634
11. D.S. Lindsay N.S. Rippey R.A. Cole L.C. Parsons J.P. Dubey R.R. Tidwell et al. Examination of the activities of 43 chemotherapeutic agents against Neospora caninum tachyzoites in cultured cells Am J Vet Res 55 7 1994 976-981
12. J.S. Barber A.J. Trees Clinical aspects of 27 cases of neosporosis in dogs Vet Rec 139 18 1996 439-443
13. F.M. Thate S.C. Laanen Successful treatment of neosporosis in an adult dog Vet Q 20 Suppl 1 1998 S113-S114
14. J.P. Dubey D.S. Lindsay A review of Neospora caninum and neosporosis Vet Parasitol 67 1 1996 1-60
15. M.E. Falagas S.L. Gorbach Clindamycin and metronidazole Med Clin N Am 79 4 1995 845-867
16. C.E. Greene M.R. Lappin A. Marks Effect of clindamycin on clinical, hematological, and biochemical parameters in clinically healthy cats J Am Anim Hosp Assoc 28 4 1992 323-326
17. G. Jacobs M. Lappin A. Marks C.E. Greene Effect of clindamycin on factor-VII activity in healthy cats Am J Vet Res 50 3 1989 393-395
18. S.C. Budsberg D.T. Kemp N. Wolski Pharmacokinetics of clindamycin phosphate in dogs after single intravenous and intramuscular administrations Am J Vet Res 53 12 1992 2333-2336
19. J.W. Spoo J.E. Riviere Sulfonamides In: Adams editor. Veterinary pharmacology and therapeutics 2001 Iowa State University Press Ames, IA 796-817
20. J.L. Gookin L.A. Trepanier S.E. Bunch Clinical hypothyroidism associated with trimethoprim-sulfadiazine administration in a dog J Am Vet Med Assoc 214 7 1999 1028-1031
21. P.H. Rowland S.A. Center S.A. Dougherty Presumptive trimethoprim-sulfadiazine-related hepatotoxicosis in a dog J Am Vet Med Assoc 200 3 1992 348-350
22. R.V. Morgan A. Bachrach Jr. Keratoconjunctivitis sicca associated with sulfonamide therapy in dogs J Am Vet Med Assoc 180 4 1982 432-434
23. D.J. Weiss J.S. Klausner Drug-associated aplastic anemia in dogs: eight cases (1984-1988) J Am Vet Med Assoc 196 3 1990 472-475
24. P.S. Sullivan K. Arrington R. West T.P. McDonald Thrombocytopenia associated with administration of trimethoprim/sulfadiazine in a dog J Am Vet Med Assoc 201 11 1992 1741-1744
25. U. Giger L.L. Werner N.J. Millichamp N.T. Gorman Sulfadiazine-induced allergy in six Doberman pinschers J Am Vet Med Assoc 186 5 1985 479-484
26. S.A. Ewing R.J. Panciera American canine hepatozoonosis Clin Microbiol Rev 16 4 2003 688-697
27. D.K. Macintire N. Vincent-Johnson A.R. Dillon B. Blagburn D. Lindsay E.M. Whitley et al. Hepatozoonosis in dogs: 22 cases (1989-1994) J Am Vet Med Assoc 210 7 1997 916-922
28. D.K. Macintire N.A. Vincent-Johnson C.W. Kane D.S. Lindsay B.L. Blagburn A.R. Dillon Treatment of dogs infected with Hepatozoon americanum: 53 cases (1989-1998) J Am Vet Med Assoc 218 1 2001 77-82
29. D.S. Lindsay B.L. Blagburn Antiprotozoan drugs In: Adams editor. Veterinary pharmacology and therapeutics 2001 Iowa State University Press Ames, IA 992-1016
30. C. Reinemeyer Canine gastrointestinal parasites In: Bonagura, Kirk editors. Kirk's current veterinary therapy XII: small animal practice 1995 WB Saunders Philadelphia 711-716
31. A.S. Fauci D.C. Dale J.E. Balow Glucocorticosteroid therapy: mechanisms of action and clinical considerations Ann Intern Med 84 3 1976 304-315
32. L.A. Cohn Glucocorticosteroids as immunosuppressive agents Semin Vet Med Surg (Small Anim) 12 3 1997 150-156
33. D.T. Boumpas G.P. Chrousos R.L. Wilder T.R. Cupps J.E. Balow Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates Ann Intern Med 119 12 1993 1198-1208
34. W. Lew J.J. Oppenheim K. Matsushima Analysis of the suppression of IL-1 alpha and IL-1 beta production in human peripheral blood mononuclear adherent cells by a glucocorticoid hormone J Immunol 140 6 1988 1895-1902
35. P.M. Dowling Immunosuppressive drug therapy Can Vet J 36 12 1995 781-783
36. J. Marx How the glucocorticoids suppress immunity Science 270 5234 1995 232-233
37. E. Falkenstein H.C. Tillmann M. Christ M. Feuring M. Wehling Multiple actions of steroid hormones - a focus on rapid, nongenomic effects Pharmacol Rev 52 4 2000 513-556
38. M. Wehling Specific, nongenomic actions of steroid hormones Ann Rev Physiol 59 1 1997 365-393
39. F. Buttgereit A. Scheffold Rapid glucocorticoid effects on immune cells Steroids 67 6 2002 529-534
40. B.J. Lipworth Therapeutic implications of non-genomic glucocorticoid activity Lancet 356 9224 2000 87-89
41. F. Buttgereit S. Krauss M.D. Brand Methylprednisolone inhibits uptake of Ca2+ and Na+ ions into concanavalin A-stimulated thymocytes Biochem J 326 Part 2 1997 329-332
42. F. Buttgereit G.R. Burmester M.D. Brand Bioenergetics of immune functions: fundamental and therapeutic aspects Immunol Today 21 4 2000 192-199
43. C.V. Oddis Idiopathic inflammatory myopathy: management and prognosis Rheum Dis Clin N Am 28 4 2002 979-1001
44. M.O. Smith Idiopathic myositides in dogs Semin Vet Med Surg (Small Anim) 4 2 1989 156-160
45. P.J. Dyck P.C. O'Brien K.F. Oviatt R.P. Dinapoli J.R. Daube J.D. Bartleson et al. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment Ann Neurol 11 2 1982 136-141
46. R.A.C. Hughes Systematic reviews of treatment for inflammatory demyelinating neuropathy J Anat 200 4 2002 331-339
47. P.A. Cuddon Acquired canine peripheral neuropathies Vet Clin N Am Small Anim Pract 32 1 2002 207-249
48. J.W. Northington M.J. Brown G.C. Farnbach S.A. Steinberg Acute idiopathic polyneuropathy in the dog J Am Vet Med Assoc 179 4 1981 375-379
49. P. Bichsel J.E. Oliver Jr. D.E. Tyler K.G. Braund Chronic polyneuritis in a Rottweiler J Am Vet Med Assoc 191 8 1987 991-994
50. A. Shores K.G. Braund R.K. McDonald Chronic relapsing polyneuropathy in a cat J Am Anim Hosp Assoc 23 1987 569-573
51. R. Malik M.P. France R. Churcher B. MacDonald Prednisone responsive neuropathy in a cat J Small Anim Pract 32 1991 529-532
52. C.W. Dewey Acquired myasthenia gravis in dogs - Part II Compend Contin Educ Pract Vet 20 1 1998 47-57
53. R.J. Joseph J.M. Carrillo V.A. Lennon Myasthenia gravis in the cat J Vet Intern Med 2 2 1988 75-79
54. J.M. Ducote C.W. Dewey J.R. Coates Clinical forms of acquired myasthenia gravis in cats Compend Contin Educ Pract Vet 21 5 1999 440-448
55. G.D. Shelton Myasthenia gravis and disorders of neuromuscular transmission Vet Clin N Am Small Anim Pract 32 1 2002 189-206
56. J.E. Maddison C.M. Waelchli-Suter R.P. Johnson Clinical remission after corticosteroid therapy of acquired myasthenia in three dogs J Am Vet Med Assoc 184 7 1984 845-848
57. A.L. Hopkins Canine myasthenia gravis J Small Anim Pract 33 1992 477-484
58. M. Dalakas Pharmacologic concerns of corticosteroids in the treatment of patients with immune-related neuromuscular diseases Neurol Clin 8 1 1990 93-118
59. R.K. McDonald V.C. Langston Use of corticosteroids and nonsteroidal anti-inflammatory agents In: Ettinger editor. Textbook of veterinary internal medicine diseases of the dog and cat 1995 WB Saunders Philadelphia 284-293
60. D.T. Boumpas G.P. Chrousos R.L. Wilder T.R. Cupps J.E. Balow Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates Ann Intern Med 119 12 1993 1198-1208
61. E. Arsura N.G. Brunner T. Namba D. Grob High-dose intravenous methylprednisolone in myasthenia gravis Arch Neurol 42 12 1985 1149-1153
62. R.K. McDonald V.C. Langston Use of corticosteroids and nonsteroidal anti-inflammatory agents In: Ettinger editor. Textbook of veterinary internal medicine diseases of the dog and cat 1995 WB Saunders Philadelphia 284-293
63. E.C. Feldman R.W. Nelson Glucocorticoid therapy In: Feldman editor. Canine and feline endocrinology and reproduction 1996 WB Saunders Philadelphia 323-336
64. J.M. Rewerts A.M. Grooters J.T. Payne J.N. Kornegay Atraumatic rupture of the gastrocnemius muscle after corticosteroid administration in a dog J Am Vet Med Assoc 210 5 1997 655-657
65. L.A. Culbert D.J. Marino R.M. Baule V.W. Knox III Complications associated with high-dose prednisolone sodium succinate therapy in dogs with neurological injury J Am Anim Hosp Assoc 34 2 1998 129-134
66. C.R. Rohrer R.C. Hill A. Fischer L.E. Fox M. Schaer P.E. Ginn et al. Efficacy of misoprostol in prevention of gastric hemorrhage in dogs treated with high doses of methylprednisolone sodium succinate Am J Vet Res 60 8 1999 982-985
67. C.R. Rohrer R.C. Hill A. Fischer L.E. Fox M. Schaer P.E. Ginn et al. Gastric hemorrhage in dogs given high doses of methylprednisolone sodium succinate Am J Vet Res 60 8 1999 977-981
68. J.P. Toombs L.G. Collins G.M. Graves D.T. Crowe D.D. Caywood Colonic perforation in corticosteroid-treated dogs J Am Vet Med Assoc 188 2 1986 145-150
69. S.M. Hanson D.R. Bostwick D.C. Twedt M.O. Smith Clinical evaluation of cimetidine, sucralfate, and misoprostol for prevention of gastrointestinal tract bleeding in dogs undergoing spinal surgery Am J Vet Res 58 11 1997 1320-1323
70. R. Neiger F. Gaschen A. Jaggy Gastric mucosal lesions in dogs with acute intervertebral disc disease: characterization and effects of omeprazole or misoprostol J Vet Intern Med 14 1 2000 33-36
71. P.J. Ihrke A.L. Norton G.V. Ling A.A. Stannard Urinary-tract infection associated with long-term corticosteroid administration in dogs with chronic skin diseases J Am Vet Med Assoc 186 1 1985 43-46
72. R.G. Miller H.S. Milner-Brown A. Mirka Prednisone-induced worsening of neuromuscular function in myasthenia gravis Neurology 36 5 1986 729-732
73. K.G. Braund A.R. Dillon R.L. Mikeal J.R. August Subclinical myopathy associated with hyperadrenocorticism in the dog Vet Pathol 17 2 1980 134-148
74. C.E. Greene M.D. Lorenz J.F. Munnell K.W. Prasse N.A. White J.M. Bowen Myopathy associated with hyperadrenocorticism in the dog J Am Vet Med Assoc 174 12 1979 1310-1315
75. K.M. Beale Azathioprine for treatment of immune-mediated diseases of dogs and cats J Am Vet Med Assoc 192 9 1988 1316-1318
76. E. Miller Immunosuppressive therapy in the treatment of immune-mediated disease J Vet Intern Med 6 4 1992 206-213
77. E. Miller The use of cytotoxic agents in the treatment of immune-mediated diseases of dogs and cats Semin Vet Med Surg (Small Anim) 12 3 1997 157-160
78. C.W. Dewey J.R. Coates J.M. Ducote J.C. Meeks J.M. Fradkin Azathioprine therapy for acquired myasthenia gravis in five dogs J Am Anim Hosp Assoc 35 5 1999 396-402
79. R.S. Dhaliwal B.E. Kitchell Cyclophosphamide Compend Contin Educ Pract Vet 21 11 1999 1059-1063
80. M.E. Stanton A.M. Legendre Effects of cyclophosphamide in dogs and cats J Am Vet Med Assoc 188 11 1986 1319-1322
81. S.E. Crow G.H. Theilen B.R. Madewell R.E. Weller A.M. Henness Cyclophosphamide-induced cystitis in the dog and cat J Am Vet Med Assoc 171 3 1977 259-262
82. J.L. Peterson C.G. Couto A.S. Hammer R.D. Ayl Acute sterile hemorrhagic cystitis after a single intravenous administration of cyclophosphamide in three dogs J Am Vet Med Assoc 201 10 1992 1572-1574
83. S.C. Charney P.J. Bergman A.E. Hohenhaus J.A. McKnight Risk factors for sterile hemorrhagic cystitis in dogs with lymphoma receiving cyclophosphamide with or without concurrent administration of furosemide: 216 cases (1990-1996) J Am Vet Med Assoc 222 10 2003 1388-1393
84. G.K. Ogilvie A.S. Moore Chemotherapy: properties, uses, and patient management In: Olgivie, Moore, (Eds.) Managing the veterinary cancer patient: a practice manual 1995 Veterinary Learning Systems Trenton, NJ 64-84
85. G. Wiederrecht E. Lam S. Hung M. Martin N. Sigal The mechanism of action of FK-506 and cyclosporin A Ann NY Acad Sci 696 1993 9-19
86. P.F. Halloran L. Kung J. Noujaim Calcineurin and the biological effect of cyclosporine and tacrolimus Transplant Proc 30 5 1998 2167-2170
87. S.L. Vaden Cyclosporine and tacrolimus Semin Vet Med Surg (Small Anim) 12 3 1997 161-166
88. B.D. Kahan Role of cyclosporine: present and future Transplant Proc 26 5 1994 3082-3087
89. D.C. Robson G.G. Burton Cyclosporine: applications in small animal dermatology Vet Dermatol 14 1 2003 1-9
90. J. Dahlinger C. Gregory J. Bea Effect of ketoconazole on cyclosporine dose in healthy dogs Vet Surg 27 1 1998 64-68
91. A.J. Patricelli R.J. Hardie J.E. McAnulty Cyclosporine and ketoconazole for the treatment of perianal fistulas in dogs J Am Vet Med Assoc 220 7 2002 1009-1016
92. K.G. Mathews C.R. Gregory Renal transplants in cats: 66 cases (1987-1996) J Am Vet Med Assoc 211 11 1997 1432-1436
93. K.A. Mathews H.R. Sukhiani Randomized controlled trial of cyclosporine for treatment of perianal fistulas in dogs J Am Vet Med Assoc 211 10 1997 1249-1253
94. A.C. Allison W.J. Kowalski C.D. Muller E.M. Eugui Mechanisms of action of mycophenolic acid Ann NY Acad Sci 696 1993 63-87
95. A.C. Allison E.M. Eugui Mycophenolate mofetil and its mechanisms of action Immunopharmacology 47 2-3 2000 85-118
96. C. Schneider R. Gold M. Schafers K.V. Toyka Mycophenolate mofetil in the therapy of polymyositis associated with a polyautoimmune syndrome Muscle Nerve 25 2 2002 286-288
97. V. Chaudhry D.R. Cornblath J.W. Griffin R. O'Brien D.B. Drachman Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases Neurology 56 1 2001 94-96
98. C.W. Dewey D.M. Booth K.L. Rinn J.R. Coates W.J. Burkholder Treatment of a myasthenic dog with mycophenolate mofetil J Vet Emerg Crit Care 10 3 2000 177-187
99. M.R.C. Banyrd R.S. Hassett The use of mycophenolate mofetil in the treatment of a case of immune-mediated glomerulonephritis in a dog Aust Vet Pract 31 3 2001 103-106
100. K.P. Platz H.W. Sollinger D.A. Hullett D.E. Eckhoff E.M. Eugui A.C. Allison RS-61443-a new, potent immunosuppressive agent Transplantation 51 1 1991 27-31
101. G. Lemm Composition and properties of IVIg preparations that affect tolerability and therapeutic efficacy Neurology 59 12 Suppl 6 2002 S28-S32
102. Appropriate uses of human immunoglobulin in clinical practice: memorandum from an IUIS/WHO meeting Bull World Health Organ 60 1 1982 43-47
103. M.C. Dalakas Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies Neurology 59 12 Suppl 6 2002 S13-S21
104. B. Buchwald R. Ahangari A. Weishaupt K.V. Toyka Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome Ann Neurol 51 6 2002 673-680
105. M.C. Dalakas Blockade of blocking antibodies in Guillain-Barré syndromes: "unblocking" the mystery of action of intravenous immunoglobulin Ann Neurol 51 6 2002 667-669
106. V. Ghetie E.S. Ward FcRn: the MHC class I-related receptor that is more than an IgG transporter Immunol Today 18 12 1997 592-598
107. Z. Yu V.A. Lennon Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases N Engl J Med 340 3 1999 227-228
108. J.C. Scott-Moncrieff W.J. Reagan Human intravenous immunoglobulin therapy Semin Vet Med Surg (Small Anim) 12 3 1997 178-185
109. M.C. Dalakas Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: present status and practical therapeutic guidelines Muscle Nerve 22 11 1999 1479-1497
110. F.G. van der Meche P.I. Schmitz A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group N Engl J Med 326 17 1992 1123-1129
111. E. Arsura Experience with intravenous immunoglobulin in myasthenia gravis Clin Immunol Immunopathol 53 2 Part 2 1989 S170-S179
112. F.L. Mastaglia B.A. Phillips P.J. Zilko Immunoglobulin therapy in inflammatory myopathies J Neurol Neurosurg Psychiatry 65 1 1998 107-110
113. J.C. Scott-Moncrieff W.J. Reagan L.T. Glickman D.B. DeNicola D. Harrington Treatment of nonregenerative anemia with human gamma-globulin in dogs J Am Vet Med Assoc 206 12 1995 1895-1900
114. D.L. Kellerman D.S. Bruyette Intravenous human immunoglobulin for the treatment of immune-mediated hemolytic anemia in 13 dogs J Vet Intern Med 11 6 1997 327-332
115. J.C. Scott-Moncrieff W.J. Reagan P.W. Snyder L.T. Glickman Intravenous administration of human immune globulin in dogs with immune-mediated hemolytic anemia J Am Vet Med Assoc 210 11 1997 1623-1627
116. A.W. Burks H.A. Sampson R.H. Buckley Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA N Engl J Med 314 9 1986 560-564
117. T.H. Brannagan III Intravenous gammaglobulin (IVIg) for treatment of CIDP and related immune-mediated neuropathies Neurology 59 12 Suppl 6 2002 S33-S40
118. R.S. Jones Reversal of atracurium neuromuscular block with neostigmine in the dog Res Vet Sci 48 1 1990 96-98
119. H.R. Adams Cholinergic pharmacology: autonomic drugs In: Veterinary pharmacology and therapeutics 2001 Iowa State University Press Ames, IA 117-136
120. S.M. Aquilonius P. Hartvig Clinical pharmacokinetics of cholinesterase inhibitors Clin Pharmacokinet 11 3 1986 236-249
121. P.R. Baker T.N. Calvey K. Chan C.M. Macnee K. Taylor Plasma clearance of neostigmine and pyridostigmine in the dog Br J Pharmacol 63 3 1978 509-512
122. P.A. Cuddon Acquired immune-mediated myasthenia gravis in a cat J Small Anim Pract 30 1989 511-516
123. G.D. Shelton M.D. Willard G.H. Cardinet III J. Lindstrom Acquired myasthenia gravis. Selective involvement of esophageal, pharyngeal, and facial muscles J Vet Intern Med 4 6 1990 281-284
124. L.M. St. John Pyridostigmine Compend Contin Educ Pract Vet 24 2 2002 92-94
125. S.R. Platt Neuromuscular complications in endocrine and metabolic disorders Vet Clin N Am Small Anim Pract 32 1 2002 125-146
126. J.P. Bonnefont F. Demaugre C. Prip-Buus J.M. Saudubray M. Brivet N. Abadi et al. Carnitine palmitoyltransferase deficiencies Mol Genet Metab 68 4 1999 424-440
127. B.W. Keene L-carnitine supplementation in the therapy of canine dilated cardiomyopathy Vet Clin N Am Small Anim Pract 21 5 1991 1005-1009
128. M.D. Kittleson B. Keene P.D. Pion C.G. Loyer Results of the multicenter spaniel trial (MUST): taurine- and carnitine-responsive dilated cardiomyopathy in American cocker spaniels with decreased plasma taurine concentration J Vet Intern Med 11 4 1997 204-211
129. G.D. Shelton Canine lipid storage myopathies In: Bonagura, Kirk, editors. Kirk's current veterinary therapy XII: small animal practice 1995 WB Saunders Philadelphia 1161-1163
130. Shelton G.D. Canine lipid storage myopathies. In: Bonagura, Kirk, editors. Kirk's current veterinary therapy XII: Samll animal practice. Philadelphia: WB Saunders 1995 1161-1163
131. G.D. Shelton W.L. Nyhan P.H. Kass B.A. Barshop R.H. Haas Analysis of organic acids, amino acids, and carnitine in dogs with lipid storage myopathy Muscle Nerve 21 9 1998 1202-1205
132. S.R. Platt C.L. Chrisman G.D. Shelton Lipid storage myopathy in a cocker spaniel J Small Anim Pract 40 1 1999 31-34
133. G.D. Shelton E. Engvall Muscular dystrophies and other inherited myopathies Vet Clin N Am Small Anim Pract 32 1 2002 103-124
134. F.L. Crane Biochemical functions of coenzyme Q10 J Am Coll Nutr 20 6 2001 591-598
135. F.L. Crane P. Navas The diversity of coenzyme Q function Mol Aspects Med 18 Suppl 1997 S1-S6
136. A.A. Zaghloul B. Gurley M. Khan H. Bhagavan R. Chopra I. Reddy Bioavailability assessment of oral coenzyme Q10 formulations in dogs Drug Dev Ind Pharm 28 10 2002 1195-1200